These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27380512)

  • 1. Cost analysis of whole genome sequencing in German clinical practice.
    Plöthner M; Frank M; von der Schulenburg JG
    Eur J Health Econ; 2017 Jun; 18(5):623-633. PubMed ID: 27380512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.
    Tsiplova K; Zur RM; Marshall CR; Stavropoulos DJ; Pereira SL; Merico D; Young EJ; Sung WWL; Scherer SW; Ungar WJ
    Genet Med; 2017 Nov; 19(11):1268-1275. PubMed ID: 28471434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Whole-genome sequencing in German clinical practice : Economic impacts of its use in selected areas of application].
    Plöthner M; Frank M; Graf von der Schulenburg JM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Feb; 60(2):143-150. PubMed ID: 27999872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational models and criteria for incorporating microbial whole genome sequencing in hospital microbiology - A systematic literature review.
    Mintzer V; Moran-Gilad J; Simon-Tuval T
    Clin Microbiol Infect; 2019 Sep; 25(9):1086-1095. PubMed ID: 31039443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GT-WGS: an efficient and economic tool for large-scale WGS analyses based on the AWS cloud service.
    Wang Y; Li G; Ma M; He F; Song Z; Zhang W; Wu C
    BMC Genomics; 2018 Jan; 19(Suppl 1):959. PubMed ID: 29363427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.
    Pasmans CTB; Tops BBJ; Steeghs EMP; Coupé VMH; Grünberg K; de Jong EK; Schuuring EMD; Willems SM; Ligtenberg MJL; Retèl VP; van Snellenberg H; de Bruijn E; Cuppen E; Frederix GWJ
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):413-414. PubMed ID: 33852815
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.
    Christensen KD; Vassy JL; Phillips KA; Blout CL; Azzariti DR; Lu CY; Robinson JO; Lee K; Douglas MP; Yeh JM; Machini K; Stout NK; Rehm HL; McGuire AL; Green RC; Dukhovny D;
    Genet Med; 2018 Dec; 20(12):1544-1553. PubMed ID: 29565423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
    Schwarze K; Buchanan J; Taylor JC; Wordsworth S
    Genet Med; 2018 Oct; 20(10):1122-1130. PubMed ID: 29446766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.
    van Nimwegen KJ; van Soest RA; Veltman JA; Nelen MR; van der Wilt GJ; Vissers LE; Grutters JP
    Clin Chem; 2016 Nov; 62(11):1458-1464. PubMed ID: 27630156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology.
    Rossen JWA; Friedrich AW; Moran-Gilad J;
    Clin Microbiol Infect; 2018 Apr; 24(4):355-360. PubMed ID: 29117578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.
    Hayeems RZ; Bhawra J; Tsiplova K; Meyn MS; Monfared N; Bowdin S; Stavropoulos DJ; Marshall CR; Basran R; Shuman C; Ito S; Cohn I; Hum C; Girdea M; Brudno M; Cohn RD; Scherer SW; Ungar WJ
    Eur J Hum Genet; 2017 Dec; 25(12):1303-1312. PubMed ID: 29158552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of whole genome sequencing for pathogen identification and surveillance - results of case studies in Europe and the Americas 2016 to 2019.
    Alleweldt F; Kara Ş; Best K; Aarestrup FM; Beer M; Bestebroer TM; Campos J; Casadei G; Chinen I; Van Domselaar G; Dominguez C; Everett HE; Fouchier RA; Grant K; Green J; Höper D; Johnston J; Koopmans MP; Oude Munnink BB; Myers R; Nadon C; Patel A; Pohlmann A; Pongolini S; Reimer A; Thiessen S; Wylezich C
    Euro Surveill; 2021 Mar; 26(9):. PubMed ID: 33663647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of WGS in Mycobacterium tuberculosis routine diagnosis.
    Cirillo DM; Cabibbe AM; De Filippo MR; Trovato A; Simonetti T; Rossolini GM; Tortoli E
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S252-S253. PubMed ID: 28043590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early technology assessment of using whole genome sequencing in personalized oncology.
    Simons M; Van De Ven M; Coupé V; Joore M; IJzerman M; Koffijberg E; Frederix G; Uyl-De Groot C; Cuppen E; Van Harten W; Retèl V
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):343-351. PubMed ID: 33910430
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing INDEL calling errors in whole genome and exome sequencing data.
    Fang H; Wu Y; Narzisi G; O'Rawe JA; Barrón LT; Rosenbaum J; Ronemus M; Iossifov I; Schatz MC; Lyon GJ
    Genome Med; 2014; 6(10):89. PubMed ID: 25426171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project.
    Christensen KD; Phillips KA; Green RC; Dukhovny D
    Value Health; 2018 Sep; 21(9):1054-1061. PubMed ID: 30224109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Economic Outcomes of Genome Sequencing Availability on Containing a Hospital Outbreak of Resistant Escherichia coli in Australia.
    Lee XJ; Elliott TM; Harris PNA; Douglas J; Henderson B; Watson C; Paterson DL; Schofield DS; Graves N; Gordon LG
    Value Health; 2020 Aug; 23(8):994-1002. PubMed ID: 32828227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole genome sequencing in oncology: using scenario drafting to explore future developments.
    van de Ven M; Simons MJHG; Koffijberg H; Joore MA; IJzerman MJ; Retèl VP; van Harten WH
    BMC Cancer; 2021 May; 21(1):488. PubMed ID: 33933021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy-Number Variants Detection by Low-Pass Whole-Genome Sequencing.
    Dong Z; Xie W; Chen H; Xu J; Wang H; Li Y; Wang J; Chen F; Choy KW; Jiang H
    Curr Protoc Hum Genet; 2017 Jul; 94():8.17.1-8.17.16. PubMed ID: 28696555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.
    Schwarze K; Buchanan J; Fermont JM; Dreau H; Tilley MW; Taylor JM; Antoniou P; Knight SJL; Camps C; Pentony MM; Kvikstad EM; Harris S; Popitsch N; Pagnamenta AT; Schuh A; Taylor JC; Wordsworth S
    Genet Med; 2020 Jan; 22(1):85-94. PubMed ID: 31358947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.